FBXO5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.700300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.509200E-01
Normal-vs-Stage2
6.223600E-02
Normal-vs-Stage3
1.382360E-01
Normal-vs-Stage4
1.911190E-01
Stage1-vs-Stage2
9.382800E-01
Stage1-vs-Stage3
1.854840E-01
Stage1-vs-Stage4
8.546000E-01
Stage2-vs-Stage3
1.461840E-01
Stage2-vs-Stage4
8.496600E-01
Stage3-vs-Stage4
1.924190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.616400E-02
Normal-vs-AfricanAmerican
1.904960E-01
Normal-vs-Asian
4.042000E-02
Caucasian-vs-AfricanAmerican
8.087400E-01
Caucasian-vs-Asian
4.307200E-01
AfricanAmerican-vs-Asian
4.230000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.131740E-02
Normal-vs-Female
1.418960E-01
Male-vs-Female
6.821700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.533580E-01
Normal-vs-Age(41-60Yrs)
2.053800E-01
Normal-vs-Age(61-80Yrs)
1.939860E-02
Normal-vs-Age(81-100Yrs)
4.837700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.629200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.131800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.928800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.288160E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.842790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.459800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.505500E-02
Normal-vs-Daily Drinker
2.181400E-03
Normal-vs-Weekly Drinker
4.271600E-01
Normal-vs-Occasional Drinker
8.010400E-02
Normal-vs-Social Drinker
6.859600E-02
Non Drinker-vs-Daily Drinker
2.291200E-01
Non Drinker-vs-Weekly Drinker
5.456400E-01
Non Drinker-vs-Occasional Drinker
5.242400E-01
Non Drinker-vs-Social Drinker
5.426400E-01
Daily Drinker-vs-Weekly Drinker
2.360800E-01
Daily Drinker-vs-Occasional Drinker
4.383700E-02
Daily Drinker-vs-Social Drinker
4.117700E-02
Weekly Drinker-vs-Occasional Drinker
8.065400E-01
Weekly Drinker-vs-Social Drinker
8.062200E-01
Occasional Drinker-vs-Social Drinker
9.996800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.721000E-01
Normal-vs-Grade 2
6.867000E-01
Normal-vs-Grade 3
6.922000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.829600E-01
Grade 1-vs-Grade 3
4.783200E-01
Grade 1-vs-Grade 4
6.721000E-01
Grade 2-vs-Grade 3
7.984400E-01
Grade 2-vs-Grade 4
6.867000E-01
Grade 3-vs-Grade 4
6.922000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.530140E-02
Normal-vs-NonDiabetic
4.640000E-02
Diabetic-vs-NonDiabetic
4.454200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.844350E-01
Normal-vs-NoPancreatitis
5.032200E-02
Pancreatitis-vs-NoPancreatitis
2.128100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.354100E-02
Normal-vs-N1
6.454100E-02
N0-vs-N1
6.402400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.651790E-01
Normal-vs-TP53-NonMutant
1.302220E-01
TP53-Mutant-vs-TP53-NonMutant
7.939600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
